OBJECTIVE: Pulmonary diseases associated with fibrosis, including scleroderma lung disease, are characterized by the accumulation of T cells in the lungs. These cells are thought to facilitate lung fibrosis, but the exact mechanisms of their profibrotic action are not clear. Several alphaV-containing integrins, including alphaVbeta3 and alphaVbeta5, have been shown to directly activate transforming growth factor beta (TGFbeta) and promote collagen accumulation. The aim of this study was to investigate whether pulmonary T cells express profibrotic integrins and regulate collagen accumulation. METHODS: Expression of integrins was assessed by immunohistochemical analysis of lung tissue, by flow cytometry using bronchoalveolar lavage fluid from patients with systemic sclerosis (SSc), and in a CCL18 overexpression animal model of pulmonary T cell infiltration. Experiments in cell cultures were performed to determine whether integrin-expressing T cells are profibrotic in cocultures with pulmonary fibroblasts and, if so, through what possible mechanism. RESULTS: Lymphocytes and integrin-positive cells were present in the lungs, and pulmonary T cells expressed integrins alphaVbeta3 and alphaVbeta5 in patients with SSc and in the animal model. Systemic administration of neutralizing anti-integrin alphaV antibody or a genetic deficiency of integrin beta3 in the CCL18 overexpression model significantly attenuated CCL18-driven pulmonary lymphocytic infiltration and collagen accumulation. Jurkat T cells overexpressing integrin alphaVbeta3 or integrin alphaVbeta5 in cocultures with primary pulmonary fibroblasts stimulated collagen accumulation and Smad2 nuclear translocation. Neutralizing anti-TGFbeta antibody attenuated the profibrotic effect of integrin-expressing T cells. CONCLUSION: Pulmonary infiltrating T lymphocytes may express integrins alphaVbeta3 and alphaVbeta5 that are necessary for lymphocytic infiltration and T cell-associated TGFbeta activation and collagen accumulation.
OBJECTIVE:Pulmonary diseases associated with fibrosis, including scleroderma lung disease, are characterized by the accumulation of T cells in the lungs. These cells are thought to facilitate lung fibrosis, but the exact mechanisms of their profibrotic action are not clear. Several alphaV-containing integrins, including alphaVbeta3 and alphaVbeta5, have been shown to directly activate transforming growth factor beta (TGFbeta) and promote collagen accumulation. The aim of this study was to investigate whether pulmonary T cells express profibrotic integrins and regulate collagen accumulation. METHODS: Expression of integrins was assessed by immunohistochemical analysis of lung tissue, by flow cytometry using bronchoalveolar lavage fluid from patients with systemic sclerosis (SSc), and in a CCL18 overexpression animal model of pulmonary T cell infiltration. Experiments in cell cultures were performed to determine whether integrin-expressing T cells are profibrotic in cocultures with pulmonary fibroblasts and, if so, through what possible mechanism. RESULTS: Lymphocytes and integrin-positive cells were present in the lungs, and pulmonary T cells expressed integrins alphaVbeta3 and alphaVbeta5 in patients with SSc and in the animal model. Systemic administration of neutralizing anti-integrin alphaV antibody or a genetic deficiency of integrin beta3 in the CCL18 overexpression model significantly attenuated CCL18-driven pulmonary lymphocytic infiltration and collagen accumulation. Jurkat T cells overexpressing integrin alphaVbeta3 or integrin alphaVbeta5 in cocultures with primary pulmonary fibroblasts stimulated collagen accumulation and Smad2 nuclear translocation. Neutralizing anti-TGFbeta antibody attenuated the profibrotic effect of integrin-expressing T cells. CONCLUSION: Pulmonary infiltrating T lymphocytes may express integrins alphaVbeta3 and alphaVbeta5 that are necessary for lymphocytic infiltration and T cell-associated TGFbeta activation and collagen accumulation.
Authors: Irina G Luzina; Sergei P Atamas; Robert Wise; Fredrick M Wigley; Hui Qing Xiao; Barbara White Journal: Am J Respir Cell Mol Biol Date: 2002-05 Impact factor: 6.914
Authors: Sergei P Atamas; Irina G Luzina; Jung Choi; Natalya Tsymbalyuk; Nicholas H Carbonetti; Ishwar S Singh; Maria Trojanowska; Sergio A Jimenez; Barbara White Journal: Am J Respir Cell Mol Biol Date: 2003-06-12 Impact factor: 6.914
Authors: Irina G Luzina; Sergei P Atamas; Robert Wise; Fredrick M Wigley; Jung Choi; Hui Qing Xiao; Barbara White Journal: Arthritis Rheum Date: 2003-08
Authors: Dezhi Mu; Stephanie Cambier; Lars Fjellbirkeland; Jody L Baron; John S Munger; Hisaaki Kawakatsu; Dean Sheppard; V Courtney Broaddus; Stephen L Nishimura Journal: J Cell Biol Date: 2002-04-22 Impact factor: 10.539
Authors: Narsa M Reddy; Suryanaraya Vegiraju; Ashley Irving; Bogdan C Paun; Irina G Luzina; Sergei P Atamas; Shyam Biswal; Navas-Acien Ana; Wayne Mitzner; Sekhar P Reddy Journal: Am J Pathol Date: 2012-02 Impact factor: 4.307
Authors: S P Atamas; I G Luzina; J Ingels; J Choi; W K Wong; D E Furst; P J Clements; A E Postlethwaite Journal: Clin Exp Immunol Date: 2010-09 Impact factor: 4.330
Authors: Pavel Kopach; Virginia Lockatell; Edward M Pickering; Ronald E Haskell; Richard D Anderson; Jeffrey D Hasday; Nevins W Todd; Irina G Luzina; Sergei P Atamas Journal: J Biol Chem Date: 2014-03-11 Impact factor: 5.157
Authors: Byung-Hyun Cha; Su Ryon Shin; Jeroen Leijten; Yi-Chen Li; Sonali Singh; Julie C Liu; Nasim Annabi; Reza Abdi; Mehmet R Dokmeci; Nihal Engin Vrana; Amir M Ghaemmaghami; Ali Khademhosseini Journal: Adv Healthc Mater Date: 2017-08-07 Impact factor: 9.933
Authors: Irina G Luzina; Pavel Kopach; Virginia Lockatell; Phillip H Kang; Ashish Nagarsekar; Allen P Burke; Jeffrey D Hasday; Nevins W Todd; Sergei P Atamas Journal: Am J Respir Cell Mol Biol Date: 2013-12 Impact factor: 6.914
Authors: Jennifer C Y Wong; Steven Y Gao; Justin G Lees; Marie B Best; Rennian Wang; Bernard E Tuch Journal: Cell Adh Migr Date: 2010-01-13 Impact factor: 3.405
Authors: Irina G Luzina; Erik P Lillehoj; Virginia Lockatell; Sang W Hyun; Katerina N Lugkey; Akihiro Imamura; Hideharu Ishida; Christopher W Cairo; Sergei P Atamas; Simeon E Goldblum Journal: J Pharmacol Exp Ther Date: 2020-11-02 Impact factor: 4.030
Authors: Erik P Lillehoj; Sang Won Hyun; Anguo Liu; Wei Guang; Avelino C Verceles; Irina G Luzina; Sergei P Atamas; K Chul Kim; Simeon E Goldblum Journal: J Biol Chem Date: 2015-05-11 Impact factor: 5.157
Authors: Irina G Luzina; Virginia Lockatell; Sang W Hyun; Pavel Kopach; Phillip H Kang; Zahid Noor; Anguo Liu; Erik P Lillehoj; Chunsik Lee; Alba Miranda-Ribera; Nevins W Todd; Simeon E Goldblum; Sergei P Atamas Journal: Am J Physiol Lung Cell Mol Physiol Date: 2016-03-18 Impact factor: 5.464